Loading company…
Salvia BioElectronics develops neuromodulation therapy for chronic migraine and cluster headache using an ultra-thin implant.
Its MySalvia Therapy is in clinical evaluation and has not yet received commercial approval. Founded in 2017 in Eindhoven, Netherlands, the company is at the Series B stage and raised EUR 53 million in May 2025, led by Innovation Industries, with participation from Invest-NL and the European Innovation Council.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in